Literature DB >> 11384894

Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression.

R D Nebes1, I J Vora, C C Meltzer, M B Fukui, R L Williams, M I Kamboh, J Saxton, P R Houck, S T DeKosky, C F Reynolds.   

Abstract

OBJECTIVE: This study examined whether evidence of cerebrovascular disease in the form of magnetic resonance imaging (MRI) signal hyperintensities in white matter was associated with depressive symptoms in a high-functioning group of normal elderly volunteers.
METHOD: Ninety-two community-dwelling elderly individuals participating in a study of white matter hyperintensities (WMHs) in normal aging whose apolipoprotein E (APOE) genotype had been determined completed the Geriatric Depression Scale and received an MRI scan. Univariate analyses of variance were used to examine the relationship between depressive symptoms and the location of WMHs (in deep white matter versus in periventricular white matter) and to determine whether WMHs were more likely to be associated with symptoms of impaired motivation and concentration or with mood symptoms. The effect on depressive symptoms of the interaction between severity of cerebrovascular disease as evidenced by WMHs and APOE genotype was also examined.
RESULTS: Hyperintensities in the deep white matter, but not in the periventricular white matter, were associated with depressive symptoms, especially symptoms of impaired motivation, concentration, and decision making. The relationship between deep WMHs and depressive symptoms was especially strong in individuals carrying the APOE-4 allele.
CONCLUSIONS: The pattern of depressive symptoms associated with WMHs in this study was similar to the pattern described in the literature as characterizing "vascular" depression in older persons with major depression. The results suggest that cerebrovascular disease may also underlie the depressive symptoms often found in older individuals who are not clinically depressed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11384894     DOI: 10.1176/appi.ajp.158.6.878

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  20 in total

1.  The greater sensitivity of elderly APOE ε4 carriers to anticholinergic medications is independent of cerebrovascular disease risk.

Authors:  Robert D Nebes; Bruce G Pollock; Subashan Perera; Edythe M Halligan; Judith A Saxton
Journal:  Am J Geriatr Pharmacother       Date:  2012-04-24

Review 2.  Mood, cognition and in vivo protein imaging: the emerging nexus in clinical neuroscience.

Authors:  Anand Kumar; Olusola Ajilore; Vladimir Kepe; Jorge R Barrio; Gary Small
Journal:  Int J Geriatr Psychiatry       Date:  2008-06       Impact factor: 3.485

3.  An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases.

Authors:  Pauline Maillard; Nicolas Delcroix; Fabrice Crivello; Carole Dufouil; Sebastien Gicquel; Marc Joliot; Nathalie Tzourio-Mazoyer; Annick Alpérovitch; Christophe Tzourio; Bernard Mazoyer
Journal:  Neuroradiology       Date:  2007-10-16       Impact factor: 2.804

Review 4.  Pharmacogenomics and therapeutic prospects in dementia.

Authors:  Ramón Cacabelos
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-03       Impact factor: 5.270

Review 5.  APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis.

Authors:  Sabrina Schilling; Anita L DeStefano; Perminder S Sachdev; Seung Hoan Choi; Karen A Mather; Charles D DeCarli; Wei Wen; Peter Høgh; Naftali Raz; Rhoda Au; Alexa Beiser; Philip A Wolf; José Rafael Romero; Yi-Cheng Zhu; Kathryn L Lunetta; Lindsay Farrer; Carole Dufouil; Lewis H Kuller; Bernard Mazoyer; Sudha Seshadri; Christophe Tzourio; Stéphanie Debette
Journal:  Neurology       Date:  2013-07-16       Impact factor: 9.910

6.  Temporal relationships between depressive symptoms and white matter hyperintensities in older men and women.

Authors:  Vonetta M Dotson; Alan B Zonderman; Michael A Kraut; Susan M Resnick
Journal:  Int J Geriatr Psychiatry       Date:  2012-03-13       Impact factor: 3.485

7.  Apolipoprotein e4 genotype and depressive symptoms as risk factors for dementia in an older korean population.

Authors:  Jae-Min Kim; Seon-Young Kim; Kyung-Yeol Bae; Sung-Wan Kim; Il-Seon Shin; Su-Jin Yang; Young-Heon Song; Jin-Sang Yoon
Journal:  Psychiatry Investig       Date:  2010-05-04       Impact factor: 2.505

Review 8.  Pharmacogenetic basis for therapeutic optimization in Alzheimer's disease.

Authors:  Ramón Cacabelos
Journal:  Mol Diagn Ther       Date:  2007       Impact factor: 4.074

Review 9.  Bipolar and major depressive disorder: neuroimaging the developmental-degenerative divide.

Authors:  Jonathan Savitz; Wayne C Drevets
Journal:  Neurosci Biobehav Rev       Date:  2009-01-21       Impact factor: 8.989

10.  Self-reported sleep quality predicts poor cognitive performance in healthy older adults.

Authors:  Robert D Nebes; Daniel J Buysse; Edythe M Halligan; Patricia R Houck; Timothy H Monk
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2009-02-09       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.